indiana, PA
Total Incidents:
305
Last Incident:
April 01, 2018
Note: Just because the latest incident is in 2017 or 2018 doesn’t mean your water is free of contaminants! There is a considerable lag between when data is collected and when it is published by the EPA.
Contaminants
Total Haloacetic Acids (HAA5)
186
Incidents
TTHM
64
Incidents
Coliform (TCR)
45
Incidents
Nitrate
10
Incidents
Total Haloacetic Acids (HAA5)
Description
Haloacetic acids occur when naturally-occurring organic and inorganic materials in the water react with the disinfectants, chlorine and chloramine.
Health Effects
Increased risk of cancer
TTHM
Description
Trihalomethanes occur when naturally-occurring organic and inorganic materials in the water react with the disinfectants, chlorine and chloramine.
Health Effects
Liver, kidney or central nervous system problems; increased risk of cancer
Coliform (TCR)
Description
Coliforms are bacteria that are naturally present in the environment and used as an indicator that other, potentially harmful, bacteria may be present. Coliforms found in more samples than allowed is a warning of potential problems.
Health Effects
Not a health threat in itself; it is used to indicate whether other potentially harmful bacteria may be present5
Nitrate
Description
Nitrates and nitrites are nitrogen-oxygen chemical units which combine with various organic and inorganic compounds. The greatest use of nitrates is as a fertilizer. Once taken into the body, nitrates are converted to nitrites.
Health Effects
Infants below the age of six months who drink water containing nitrite in excess of the MCL could become seriously ill and, if untreated, may die. Symptoms include shortness of breath and blue-baby syndrome.
All Incidents
| Water System | Type | Measure | Violation | Effects | Begin Date |
|---|---|---|---|---|---|
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2018-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-07-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-07-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-07-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-07-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-07-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-07-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2017-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-04-01 |
| ICMSA ARCADIA | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-04-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2017-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-04-01 |
| ICMSA ARCADIA | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-04-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2017-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-04-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2017-04-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2017-04-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2017-04-01 |
| ICMSA ARCADIA | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-04-01 |
| ICMSA ARCADIA | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-04-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2017-01-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2016-10-01 |
| ICMSA ROSSITER | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA ARCADIA | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2016-10-01 |
| ICMSA ARCADIA | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA ROSSITER | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA ROSSITER | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA ARCADIA | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA ARCADIA | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA ROSSITER | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-10-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-07-01 |
| FOUR CS | Nitrate | MCL, Average | Maximum Contaminant Level Violation | Infants below the age of six months who drink water containing nitrate in excess of the MCL could become seriously ill and, if untreated, may die. Symptoms include shortness of breath and blue-baby syndrome. | 2016-07-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-07-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-07-01 |
| FOUR CS | Nitrate | MCL, Average | Maximum Contaminant Level Violation | Infants below the age of six months who drink water containing nitrate in excess of the MCL could become seriously ill and, if untreated, may die. Symptoms include shortness of breath and blue-baby syndrome. | 2016-07-01 |
| ICMSA ROSSITER | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2016-07-01 |
| FOUR CS | Nitrate | MCL, Average | Maximum Contaminant Level Violation | Infants below the age of six months who drink water containing nitrite in excess of the MCL could become seriously ill and, if untreated, may die. Symptoms include shortness of breath and blue-baby syndrome. | 2016-07-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-07-01 |
| ICMSA ROSSITER | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2016-07-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2016-07-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2016-07-01 |
| ICMSA CHERRYTREE | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2016-07-01 |
| ICMSA ROSSITER | TTHM | MCL, Average | Maximum Contaminant Level Violation | Liver, kidney or central nervous system problems; increased risk of cancer | 2016-07-01 |
| ICMSA CHERRYTREE | Total Haloacetic Acids (HAA5) | MCL, Average | Maximum Contaminant Level Violation | Increased risk of cancer | 2016-07-01 |